<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="4761">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04741217</url>
  </required_header>
  <id_info>
    <org_study_id>288629</org_study_id>
    <nct_id>NCT04741217</nct_id>
  </id_info>
  <brief_title>Aerosolisation During Respiratory Procedures</brief_title>
  <official_title>A Proof of Concept Study to Evaluate Aerosol Generation During Non-Invasive Positive Pressure Respiratory Procedures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Guy's and St Thomas' NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Guy's and St Thomas' NHS Foundation Trust</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Currently, a major issue within respiratory medicine is undertaking procedures that generate&#xD;
      aerosolisation with the concern of spreading infection, such as the SARS-COV-2/COVID-19&#xD;
      virus. It is anecdotally reported that lung function testing and positive airways pressure&#xD;
      devices used in clinical practice are aerosol generating procedures however the data to&#xD;
      support this is limited. With the advent of high-speed imaging systems that can capture and&#xD;
      quantify particle size and velocity we aim to investigate the aerosol generation in routine&#xD;
      non-invasive positive pressure respiratory procedures.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 1, 2021</start_date>
  <completion_date type="Anticipated">September 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Characterisation of aerosolised respiratory droplets</measure>
    <time_frame>1 year</time_frame>
    <description>Performed using high-speed imaging and particle size counters</description>
  </primary_outcome>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Healthy</condition>
  <condition>Respiratory Tract Infections</condition>
  <condition>Lung Infection</condition>
  <condition>Droplet Spread</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Not an interventional study</intervention_name>
    <description>No interventions are implemented. This is an observational study of respiratory droplet aerosolisation during respiratory procedures.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy subjects&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 18-80 years&#xD;
&#xD;
          -  Healthy subjects with no active medical conditions or previous pneumothorax&#xD;
&#xD;
          -  Cognitively and linguistically able to follow instructions given in English and&#xD;
             provide informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Significant respiratory, cardiac or neurological conditions or previous pneumothorax&#xD;
&#xD;
          -  Smoking history greater than 10 pack years&#xD;
&#xD;
          -  Acute illness at the time of assessment&#xD;
&#xD;
          -  Allergies to latex, metals or local anaesthetic agents&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
  </eligibility>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>February 3, 2021</study_first_submitted>
  <study_first_submitted_qc>February 3, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 5, 2021</study_first_posted>
  <last_update_submitted>February 3, 2021</last_update_submitted>
  <last_update_submitted_qc>February 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Respiratory Tract Infections</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Anonymised data may be shared based upon consideration of reasonable requests from researchers with a stated objective.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

